Patrick Soon-Shiong, Chairman of Chan Soon-Shiong Family Foundation, Executive Chairman at ImmunityBio, and Executive Chairman of the Los Angeles Times, shared on X:
“As I scan the literature, I continue to be amazed of how far back the realization that the immune system matters regardless of the tumor type and that with loss of T and NK cells, survival is so significantly reduced. Here is a paper since 2012 that states,
‘These patients could be proposed for specific treatment approaches, including innovative strategies for immune restoration.’
Just imagine if such an approach was available.”
Title: CD4 lymphopenia to identify end-of-life metastatic cancer patients
Authors: Julien Péron, Claire Cropet, Olivier Tredan, Thomas Bachelot, Isabelle Ray-Coquard, Gilles Clapisson, Sylvie Chabaud, Irene Philip, Christophe Borg, Philippe Cassier, Inthidar Labidi Galy, Catherine Sebban, David Perol, Pierre Biron, Christophe Caux, Christine Menetrier-Caux, Jean-Yves Blay
Read the Full Article on European Journal of Cancer.
Other posts featuring Patrick Soon-Shiong on OncoDaily.
